Garlandsurgical
Worcester, GB · 1 known investors
Garland Surgical develops the TriActiv Hip (formerly MaltaHip), a total hip replacement implant using a patented tri-axial design intended to improve mobility, stability, and durability while reducing revision surgeries. Aimed at orthopaedic surgeons and hip arthroplasty patients, the company plans to commercialize the device through OEM licensing, with an initial US market entry via FDA 510(k).
HardwareHealthtechMedical Devices
Founders & leadership
SM
Simon MifsudFounder & Group Chief Executive Officer
JS
John ShaplandChief Technology Officer
DD
Donald DalliPrincipal Development Engineer & Tri-Activ Co-Inventor